SIMCERE PHARMAC. GRP LTD (S2P) — Defensive Interval Ratio

Latest as of December 2025: 279 days

SIMCERE PHARMAC. GRP LTD (S2P) has a Defensive Interval Ratio of 279 days as of December 2025. Defensive assets of €2.56 Billion (cash €-, short-term investments €65.53 Million, receivables €2.49 Billion) cover 279 days of daily cash needs of €9.16 Million/day. Check S2P tangible net worth ratio to evaluate the tangible quality of the company's equity base.

Defensive Interval Ratio

279 days
Days of operational coverage

Defensive Assets

€2.56 Billion
Cash + ST Investments + Receivables

Daily Cash Need

€9.16 Million
Current Liabilities ÷ 365

Current Liabilities

€3.35 Billion
EUR

SIMCERE PHARMAC. GRP LTD Defensive Interval Ratio (2021–2025)

This chart shows how SIMCERE PHARMAC. GRP LTD's Defensive Interval Ratio has evolved across 5 annual periods from 2021 to 2025. As of December 2025, the ratio stands at 279 days, meaning defensive assets of €2.56 Billion can fund 279 days of operations without new revenue. Also explore S2P year-over-year net asset growth to track the company's year-over-year net asset growth rate.

Annual Defensive Interval Ratio for SIMCERE PHARMAC. GRP LTD (2021–2025)

The table below presents the year-by-year Defensive Interval Ratio for SIMCERE PHARMAC. GRP LTD from 2021 to 2025, covering 5 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see S2P company net worth.

Year DIR (days) Defensive Assets (EUR) Daily Cash Need Cash ST Investments Change (days)
2025 279 days €2.56 Billion €9.16 Million/day €- €65.53 Million ▼ -37 days
2024 317 days €2.36 Billion €7.47 Million/day €- €10.00 Million ▲ +44 days
2023 273 days €2.01 Billion €7.36 Million/day €- €11.14 Million ▼ -76 days
2022 349 days €2.84 Billion €8.13 Million/day €- €964.23 Million ▼ -35 days
2021 384 days €3.23 Billion €8.39 Million/day €- €1.21 Billion
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)